PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Treatment algorithms featured in Brain Trauma Foundation’s update of guidelines for care of patients with penetrating traumatic brain injury

Practical flowcharts balance complexity with convenience for use during emergencies

2026-02-17
(Press-News.org) February 17, 2026 — The Brain Trauma Foundation has updated the 2001 evidence-based guidelines for the care of patients with penetrating traumatic brain injury (pTBI). A working group of more than 30 expert panelists developed over 30 new evidence-based recommendations. To provide a bridge between these recommendations and complexities of care at the bedside, panelists also used a rigorous Delphi process to develop consensus statements as well as treatment algorithms for the guidelines. The guidelines and algorithms are published together as a supplement to the March 2026 issue of Neurosurgery, the official publication of the Congress of Neurological Surgeons (CNS), which is part of the Lippincott portfolio by Wolters Kluwer.

The guidelines were reviewed for evidence-based integrity and endorsed by the American Association of Neurological Surgeons and Congress of Neurological Surgeons.

Saving lives requires combating nihilism with information

“There are many misconceptions in medicine, and the idea that all penetrating brain injury is uniformly non-survivable is certainly one of them,” say Gregory W. J. Hawryluk, MD, PhD, of the Cleveland Clinic; Randy Bell, MD, CAPT (ret), MC, USN, of the University of South Dakota; and colleagues. They emphasize two main points: Patients with pTBI who survive to reach a trauma center, in whom care is not considered futile, often have the same or better outcomes than comparably injured patients with closed TBI, and in nearly every circumstance pTBI is a surgical disease. 

The new care pathways address the needs of diverse pTBI patients

The algorithms include a master pathway relevant to all patients and “toolkits” to address care issues that affect only some patients. The master care pathway discusses the pre-hospital or field setting, then lays out steps for patient care at the hospital: 

Immediately re-apply advanced trauma life support (ATLS) principles, with simultaneous laboratory and image-based analysis. Immediate neurosurgical consultation is recommended. Follow ATLS protocols strictly, as the striking nature of pTBI can be distracting. It is crucial to identify the entry and, if present, exit wound, keeping in mind the potential for multiple penetrating injuries and multiple injured organ systems. Beware that nail gun injuries are often occult, as are stab wounds where the implement has been removed. If significant skull disruption is encountered, avoid compressive dressings and do not probe the wound or debride brain tissue or other damaged tissue at this point.  

When the patient is sufficiently resuscitated, send them for immediate CT and CT angiography (CTA) of the head and neck. Because CT images can be subject to scatter, skull x-rays may have a role in demonstrating the presence and location/trajectory of radio-opaque foreign bodies. Some foreign bodies (e.g., glass, wood, and some rocks) are radiolucent and require MRI if it is felt that can be done safely. Strongly consider additional imaging, including cerebral angiography, at this point if traumatic vascular injury including traumatic aneurysms are noted on CTA or otherwise suspected.

In addition to standard laboratory analysis, viscoelastic testing can be helpful to ascertain precise coagulation abnormalities and guide the choice of corrective measures. Additional resuscitation, including component (1:1:1) or whole blood transfusion, should begin immediately in patients who have more than minimal injury, in anticipation of substantial blood loss during surgery. Synthesize all information gathered in preparation for additional decision-making. Base decisions on medical futility rather than short- or long-term prognosis or eventual functional outcome. The working group defined medical futility as: “A proposed therapy should not be performed because available data show that it will not improve the patient’s condition.” Futility is distinct from survivability, the potential for a patient to survive if treated aggressively. The algorithms portion of the supplement includes a toolkit for assessing futility in cases of pTBI, as well as toolkits for surgical management in general, managing a protruding foreign body, managing severe injury (multiple injured lobes, mass lesion, midline shift, or edema), managing penetrating skull base injury, and managing traumatic vascular injury.

Read Article: Treatment Algorithms From the Brain Trauma Foundation Guidelines for the Management of Penetrating Traumatic Brain Injury, Second Edition

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health.

###

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.

END


ELSE PRESS RELEASES FROM THIS DATE:

Over 40% of musicians experience tinnitus; hearing loss and hyperacusis also significantly elevated

2026-02-17
A new systematic review and meta-analysis published in Otolaryngology–Head and Neck Surgery, the official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF), reveals that musicians face substantially higher rates of tinnitus, hearing loss, and hyperacusis compared to non-musicians. The study, which pooled data from 67 studies encompassing more than 28,000 musicians across 21 countries. The research found that 42.6% of musicians reported tinnitus (ringing in the ears), compared ...

Artificial intelligence predicts colorectal cancer risk in ulcerative colitis patients

2026-02-17
People with ulcerative colitis (UC), a chronic inflammatory bowel disease, are up to four times more likely to develop colorectal cancer than the general population. Low‑grade dysplasia (LGD) — abnormal or precancerous lesions — can be an early warning sign, but only a fraction of UC‑LGD cases progress to cancer. This makes it challenging for clinicians and patients to make informed care decisions, ranging from continued surveillance to preventative surgery. Now, a new study led by researchers at University ...

Mayo Clinic installs first magnetic nanoparticle hyperthermia system for cancer research in the US

2026-02-17
ROCHESTER, Minn. — Mayo Clinic collaborated with New Phase Ltd. to install the first magnetic nanoparticle-mediated hyperthermia machine for cancer research in the U.S. Hyperthermia is a procedure that uses heat to damage and kill cancer cells. The investigational machine will support research evaluating the safety, feasibility and potential effectiveness of this approach in cancer treatment. "We have known for more than a century that temperature is the Achilles' heel of cancer, but conventional hyperthermia has limitations and is not widely available," says Scott Lester, M.D., a radiation ...

Calibr-Skaggs and Kainomyx launch collaboration to pioneer novel malaria treatments

2026-02-17
La Jolla, CA and Palo Alto, CA—The Calibr-Skaggs Institute for Innovative Medicines at Scripps Research and Kainomyx, Inc., today announced a new research collaboration to accelerate the discovery and development of next-generation antimalarial drugs. This partnership, supported by the Gates Foundation, brings together Calibr-Skaggs’ world-class drug discovery platform and Kainomyx’s innovative focus on cytoskeletal targets in the Plasmodium species of the parasite that are responsible for the deadliest form of malaria. Meeting the Unmet Need in Malaria Malaria remains one of the world’s most devastating infectious diseases, with over 280 million ...

JAX-NYSCF Collaborative and GSK announce collaboration to advance translational models for neurodegenerative disease research

2026-02-17
The Jackson Laboratory–New York Stem Cell Foundation Collaborative (JAX-NYSCF) today announced a five-year strategic research collaboration with GSK focused on advancing human cellular models of neurodegenerative disease, including Alzheimer’s disease. The collaboration reflects a strategic focus that brings together human stem cell research, advanced data science tools, and large-scale research systems to help close a long-standing gap between scientific discovery and the development of new medicines. The goal is to generate ...

Classifying pediatric brain tumors by liquid biopsy using artificial intelligence

2026-02-17
(MEMPHIS, Tenn. – February 17, 2026) Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer’s biology. However, technological limitations with the small amount of ctDNA available from pediatric brain tumor liquid biopsies have previously stymied broad use of the approach for those patients. To address this, St. Jude Children’s Research Hospital scientists, in collaboration with scientists at the Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research ...

Insilico Medicine initiates AI driven collaboration with leading global cancer center to identify novel targets for gastroesophageal cancers

2026-02-17
Cambridge, MA, February 17, 2025 — Insilico Medicine (“Insilico”, 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and Memorial Sloan Kettering Cancer Center (MSK) have entered into a collaborative research agreement aimed at discovering new therapeutic targets for gastroesophageal malignancies. The initiative builds on MSK’s global leadership in this field under the direction of Yelena Y. Janjigian, MD, Carroll and Milton Petrie Chair; Chief, GI ...

Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer

2026-02-17
A new UCLA investigator-initiated study sponsored by the UCLA Health Jonsson Comprehensive Cancer Center has found that adding immunotherapy to standard chemotherapy before surgery is safe and shows promise for some patients with borderline-resectable pancreatic cancer, a disease that has historically been difficult to treat. The findings, published in Nature Communications, show that while the combination did not produce a clear survival advantage for most patients, a notable subset experienced unusually ...

A “smart fluid” you can reconfigure with temperature

2026-02-17
Imagine a “smart fluid” whose internal structure can be rearranged just by changing temperature. In a new study in Matter, researchers report a way to overcome a long-standing limitation in a class of “smart fluids” called nematic liquid crystal microcolloids, allowing for reconfigurable self-assembly of micrometer-sized particles dispersed in a nematic liquid crystal host. The persistent challenge has been that conventional microparticles can induce strong distortions and topological defects in the liquid crystal, which in turn can drive irreversible sticking and clumping, making ...

New research suggests myopia is driven by how we use our eyes indoors

2026-02-17
New York, NY — For years, rising rates of myopia — or nearsightedness — have been widely attributed to increased screen time, especially among children and young adults. But new research from scientists at the SUNY College of Optometry suggests the story may be more complicated — and more human. In a new study to be published in Cell Reports, researchers propose that myopia may be driven less by screens themselves and more by a common indoor visual habit: prolonged close-up focus in low-light environments, which limits how much light reaches ...

LAST 30 PRESS RELEASES:

Maternal smoking during pregnancy may be linked to higher blood pressure in children, NIH study finds

New Lund model aims to shorten the path to life-saving cell and gene therapies

Researchers create ultra-stretchable, liquid-repellent materials via laser ablation

Combining AI with OCT shows potential for detecting lipid-rich plaques in coronary arteries

SeaCast revolutionizes Mediterranean Sea forecasting with AI-powered speed and accuracy

JMIR Publications’ JMIR Bioinformatics and Biotechnology invites submissions on Bridging Data, AI, and Innovation to Transform Health

Honey bees navigate more precisely than previously thought

Air pollution may directly contribute to Alzheimer’s disease

Study finds early imaging after pediatric UTIs may do more harm than good

UC San Diego Health joins national research for maternal-fetal care

New biomarker predicts chemotherapy response in triple-negative breast cancer

Treatment algorithms featured in Brain Trauma Foundation’s update of guidelines for care of patients with penetrating traumatic brain injury

Over 40% of musicians experience tinnitus; hearing loss and hyperacusis also significantly elevated

Artificial intelligence predicts colorectal cancer risk in ulcerative colitis patients

Mayo Clinic installs first magnetic nanoparticle hyperthermia system for cancer research in the US

Calibr-Skaggs and Kainomyx launch collaboration to pioneer novel malaria treatments

JAX-NYSCF Collaborative and GSK announce collaboration to advance translational models for neurodegenerative disease research

Classifying pediatric brain tumors by liquid biopsy using artificial intelligence

Insilico Medicine initiates AI driven collaboration with leading global cancer center to identify novel targets for gastroesophageal cancers

Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer

A “smart fluid” you can reconfigure with temperature

New research suggests myopia is driven by how we use our eyes indoors

Scientists develop first-of-its-kind antibody to block Epstein Barr virus

With the right prompts, AI chatbots analyze big data accurately

Leisure-time physical activity and cancer mortality among cancer survivors

Chronic kidney disease severity and risk of cognitive impairment

Research highlights from the first Multidisciplinary Radiopharmaceutical Therapy Symposium

New guidelines from NCCN detail fundamental differences in cancer in children compared to adults

Four NYU faculty win Sloan Foundation research fellowships

Personal perception of body movement changes when using robotic prosthetics

[Press-News.org] Treatment algorithms featured in Brain Trauma Foundation’s update of guidelines for care of patients with penetrating traumatic brain injury
Practical flowcharts balance complexity with convenience for use during emergencies